Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HOPPS: Hyperbaric Oxygen for Persistent Post-concussive Symptoms
NCT01306968Phase 2Completed
- Sponsor
- U.S. Army Medical Research and Development Command
- Start
- Feb 2011
- Primary completion
- Aug 2012
- Modality
- NPI (Non-Pharmacological Intervention)
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of hyperbaric oxygen therapy in Post-concussion syndrome (PCS) (4 arms), sponsored by U.S. Army Medical Research and Development Command. Primary endpoints: Post-Intervention Post-concussion Symptom Scores Using Rivermead Post Concussion Symptoms Questionnaire at Day 70 and Change in Post-concussion Symptom Scores Using Rivermead Post Concussion Symptoms Questionnaire at Day 70. Started Feb 2011; status: completed.
02
Drugs
hyperbaric oxygen therapy
03
Conditions
Post-concussion syndrome (PCS)
Beyond the preview
Go deeper on NCT01306968.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01306968.